An update from Howard Wolinsky — on active surveillance + type 2 diabetes (and the power of diet)

So regular readers will be aware of several articles by Howard Wolinsky on his experiences as a man monitoring low-risk prostate cancer on active surveillance since 2010. Apparently this was insufficiently challenging. In June he was diagnosed with type 2 diabetes (T2B) as well. … READ MORE …

Howard Wolinsky has a new problem …

… and it’s one that is not exactly uncommon for older men (with or without prostate cancer). … To get the scoop, just click here. … READ MORE …

Howard Wolinsky’s continuing journey on active surveillance

Following his most recent check-in with his urologist, Howard tells us about things related to how the new USPSTF guidelines and tests like liquid biopsies might affect the monitoring of low-risk prostate cancer patients. … READ MORE …

Informing the media community about prostate cancer and its management

A new article on the HealthNewsReview web site addresses issues related to the diagnosis of prostate cancer and the management of low-risk forms of the disease using active surveillance. … READ MORE …

Howard Wolinsky takes another step on his active surveillance travels

In his latest post on the MedPage Today web site, Howard Wolinsky (a freelance journalist based in the Chicago area), who has been on active surveillance since 2010, writes about the result of his most recent rebiopsy. His last one was in 2013. There was (again) “no evidence of malignancy” in the post-biopsy pathology report. … READ MORE …

Tales from “a poster boy” for active surveillance

Howard Wolinksy is  a journalist — by training and by profession. In 2010, a while after he finished full-time employment with the Chicago Sun-Times, he was diagnosed with low-risk prostate cancer, and he has been documenting the impact ever since. … READ MORE …